Ondansetron ODT 4 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FE9JA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,682
Award facts
- Contract value 100% obligated
- $15,681.91 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerSourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on January 20, 2026, valued at $15,681.91 for the supply of Ondansetron ODT 4 mg tablets (30-count packages). This firm fixed-price delivery order, which must be completed by January 21, 2026, was competitively awarded without set-aside designation by the Defense Logistics Agency (DLA), the federal agency responsible for supply chain management across the Department of Defense. The award represents a task order executed under AmerSourceBergen's parent company Cencora, Inc.'s existing Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical and medical supplies to support military healthcare programs globally.
Ondansetron is an antiemetic medication commonly used in military and veteran healthcare settings to prevent nausea and vomiting, particularly in post-operative and chemotherapy contexts. The DLA's utilization of its pharmaceutical prime vendor contract with Cencora/AmerSourceBergen demonstrates the efficiency of indefinite delivery vehicles in enabling rapid fulfillment of recurring pharmaceutical needs across the military medical supply chain. This delivery order exemplifies the broader pharmaceutical distribution partnership between the federal government and AmerSourceBergen, which has established itself as a critical vendor capable of meeting federal procurement requirements through competitive processes across multiple therapeutic domains and product categories.
Quick answers
Who was awarded contract SPE2DR26FE9JA?
SPE2DR26FE9JA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FE9JA worth?
The government has obligated $15,682 on SPE2DR26FE9JA.
Is contract SPE2DR26FE9JA an order under another contract?
Yes. SPE2DR26FE9JA is a delivery order under SPE2DR25D3104, an indefinite delivery contract.
Was contract SPE2DR26FE9JA competed?
The extent of competition for SPE2DR26FE9JA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award